Fiercebiotech

Published November 9, 2026

J&J-backed Delix drums up $100M series C for non-hallucinatory psychedelic for depression

Read the full story at Fiercebiotech

The neuroplastogen drug class is usually aligned with psychedelics such as ketamine or psilocybin, or second-generation drugs such as J&J's Spravato.